Molecule Details
| InChIKey | KAZQGFWXNPUZQP-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-[2-(4,6-Bis-ethylamino-[1,3,5]triazin-2-ylamino)-ethyl]-benzenesulfonamide |
| Canonical SMILES | CCNc1nc(NCC)nc(NCCc2ccc(S(N)(=O)=O)cc2)n1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.69 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q16790 | CA9 | Homo sapiens | Human | PF00194 | 8.5 | Ki | ChEMBL;BindingDB |
| P00918 | CA2 | Homo sapiens | Human | PF00194 | 7.6 | Ki | ChEMBL;BindingDB |
| P18505 | GABRB1 | Homo sapiens | Human | PF02931 PF02932 | 7.6 | pIC50 | TTD_MultiTarget |
| P00915 | CA1 | Homo sapiens | Human | PF00194 | 7.0 | Ki | ChEMBL;BindingDB |